Which sedative best protects the brain after injury? trial pits three common drugs Head-to-Head
NCT ID NCT07678216
First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time
Summary
This trial compares three sedatives—propofol, midazolam, and dexmedetomidine—for controlling pressure inside the skull after urgent brain surgery for moderate-to-severe traumatic brain injury. Adults who have had surgery within 24 hours of injury will receive one of the three drugs for 24 hours. The study measures how well each drug controls brain pressure, how deeply it sedates, and how it affects ICU outcomes like time on a ventilator and survival.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- propofol, midazolam, dexmedetomidine
- What this could lead to
- If one sedative proves better at controlling brain pressure, it could improve recovery and reduce ICU time for people with traumatic brain injury.
- What could go wrong
- This is a single-center trial with 210 participants, so results may not apply to all patients. The study only looks at 24 hours of sedation, not long-term outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE-TO-SEVERE TRAUMATIC BRAIN INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Aswan University Hospital
Asyut, Asyut Governorate, 81528, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.